Behavioral Neurology & Neuropsychiatry Certification Examination Committee Contributors
Robin A. Hurley, MD, FANPA, W.G. Hefner VA Medical Center
Disclosures: Employee of the Veterans Administration (VA). VA received research funding from Teva Pharma for posttraumatic migraine study, Aptinyx, Inc for PTSD and sleep study, and Avanir Pharmaceuticals for traumatic brain injury and aggression study. Role: Principal investigator. VA received research funding for the million veteran program, the MIRECC, relating to PTSD and TBI, funding for a genetics study called PRIME, and funding for a study of suvorexant for PTSD-related insomnia. No personal compensation received related to the research funding received.
James R. Bateman, III, MD, Wake Forest School of Medicine
Disclosures: Nothing to disclose.
Donald P. Eknoyan, MD, Kaiser Permanente
Disclosures: Nothing to disclose.
Kyle J. Steinman, MD, MAS, University of Washington/Seattle Children's Hospital
Disclosures: Received research funding from a government organization.
Colin J. Harrington, MD, Rhode Island Hospital and Brown University Medical School
Disclosures: Nothing to disclose.
Claudia R. Padilla, MD, Baylor Scott & White AT&T Memory Center
Disclosures: Nothing to disclose.
Jonathan H. Woodcock, MD, University of Colorado – Anschutz Medical Campus
Disclosures: Nothing to disclose.
Michael J. Schrift, DO, MA, FANPA, University of Washington Department of Psychiatry and Behavioral Science
Disclosures: Nothing to disclose.
Miles G. Cunningham, MD, McLean Hospital
Disclosures: Nothing to disclose.
Mary E. Quiceno, MD, University of North Texas Health Science Center
Disclosures: Serve as Appeals Advisory Panel member for NFL Concussion Injury Litigation/Settlement Program. Employed by Parexel as a Medical Director.